Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Progesterone receptor B (PR-B) is a full-length nuclear hormone receptor acting primarily as an activator for progesterone-mediated gene expression. It differs structurally from its shorter counterpart PRA due to an extra N-terminal region conferring unique regulatory properties. Its activity underlies many normal reproductive processes—and imbalances between its expression relative to other isoforms contribute significantly to pathologies such as certain cancers.
Ligand binding, receptor dimerization, nuclear translocation, DNA binding (to progesterone response elements), co-regulator recruitment, transcriptional activation/repression.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Progesterone Receptor B (PR-B).